Loading…

Synthesis, analgesic, anti-inflammatory, COX/5-LOX inhibition, ulcerogenic evaluation, and docking study of benzimidazole bearing indole and benzophenone analogs

•Synthesis of benzimidazole analogs bearing benzophenone and indole moieties 10a-j.•Screening of synthesized compounds for in vivo analgesic, anti-inflammatory, and ulcerogenic evaluation.•In vitro analysis of COX-1, COX-2, and 5-LOX inhibition.•Molecular docking studies supported the investigation...

Full description

Saved in:
Bibliographic Details
Published in:Journal of molecular structure 2022-07, Vol.1259, p.132741, Article 132741
Main Authors: Nagesh, Khadri M.J., Prashanth, T., Khamees, Hussien Ahmed, Khanum, Shaukath Ara
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c312t-aa0cb86a1ace6e3d92ca098697abd210878846d31f02a15c198f16bdab4ab5933
cites cdi_FETCH-LOGICAL-c312t-aa0cb86a1ace6e3d92ca098697abd210878846d31f02a15c198f16bdab4ab5933
container_end_page
container_issue
container_start_page 132741
container_title Journal of molecular structure
container_volume 1259
creator Nagesh, Khadri M.J.
Prashanth, T.
Khamees, Hussien Ahmed
Khanum, Shaukath Ara
description •Synthesis of benzimidazole analogs bearing benzophenone and indole moieties 10a-j.•Screening of synthesized compounds for in vivo analgesic, anti-inflammatory, and ulcerogenic evaluation.•In vitro analysis of COX-1, COX-2, and 5-LOX inhibition.•Molecular docking studies supported the investigation of the ligand binding to their target protein.•Viable dual inhibition of COX/5-LOX by the synthetic analogs. Inflammation therapy is particularly focused on the development of safer non-steroidal anti-inflammatory drugs (NSAIDs), administered to control inflammation. It is typically considered that dual-inhibition of COX/5-LOX, which improves efficacy and has fewer side effects, is an effective technique for combating inflammation. In this perspective, the series of titled compounds (10a-j) were designed, synthesized, and characterized following with the anti-inflammatory, analgesic, and ulcerogenic evaluation. The investigation of the potentiality of the titled compounds (10a-j) displayed a high degree of anti-inflammatory activity. The compounds displaying potential analgesic activity were identified and validated further for evaluation of analgesic, anti-inflammatory activity, and subsequent ulcerogenic evaluation. In addition, the COX-1, COX-2, and 5-LOX analyses were carried out in vitro. Among (10a-j) series, compound 10c with para substitution of fluoro group on the benzoyl ring and two chloro groups at ortho position in phenyl ring of benzophenone was observed to have good inhibitory potency. Furthermore, the in silico docking study was performed by using AutoDock tools docking software.
doi_str_mv 10.1016/j.molstruc.2022.132741
format article
fullrecord <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1016_j_molstruc_2022_132741</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022286022004148</els_id><sourcerecordid>S0022286022004148</sourcerecordid><originalsourceid>FETCH-LOGICAL-c312t-aa0cb86a1ace6e3d92ca098697abd210878846d31f02a15c198f16bdab4ab5933</originalsourceid><addsrcrecordid>eNqFUMtOwzAQtBBIlMcvIH9AU2ynTZ0bqOIlIXEAJG7Wxt60WxIb2SlS-zf8KQmFM6ed3dkZjYaxCykmUsjicj1pQ5O6uLETJZSayFzNp_KAjaSeq0wLOT1kI9EzmdKFOGYnKa2FELIXj9jX89Z3K0yUxhw8NMse2gF2lJGvG2hb6ELcjvni6e1ylj0-vXHyK6qoo-DHfNNYjGGJnizHT2g2sL-Dd9wF-05-yVO3cVseal6h31FLDnahwX6DONDk3bAOiuEhfKzQB48_ccIynbGjGpqE57_zlL3e3rws7vsodw-L68fM5lJ1GYCwlS5AgsUCc1cqC6LURTmHyikp9FzraeFyWQsFcmZlqWtZVA6qKVSzMs9PWbH3tTGkFLE2H5FaiFsjhRmKNmvzV7QZijb7onvh1V6IfbpPwmiSJfQWHUW0nXGB_rP4BuhKjrs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Synthesis, analgesic, anti-inflammatory, COX/5-LOX inhibition, ulcerogenic evaluation, and docking study of benzimidazole bearing indole and benzophenone analogs</title><source>ScienceDirect Freedom Collection</source><creator>Nagesh, Khadri M.J. ; Prashanth, T. ; Khamees, Hussien Ahmed ; Khanum, Shaukath Ara</creator><creatorcontrib>Nagesh, Khadri M.J. ; Prashanth, T. ; Khamees, Hussien Ahmed ; Khanum, Shaukath Ara</creatorcontrib><description>•Synthesis of benzimidazole analogs bearing benzophenone and indole moieties 10a-j.•Screening of synthesized compounds for in vivo analgesic, anti-inflammatory, and ulcerogenic evaluation.•In vitro analysis of COX-1, COX-2, and 5-LOX inhibition.•Molecular docking studies supported the investigation of the ligand binding to their target protein.•Viable dual inhibition of COX/5-LOX by the synthetic analogs. Inflammation therapy is particularly focused on the development of safer non-steroidal anti-inflammatory drugs (NSAIDs), administered to control inflammation. It is typically considered that dual-inhibition of COX/5-LOX, which improves efficacy and has fewer side effects, is an effective technique for combating inflammation. In this perspective, the series of titled compounds (10a-j) were designed, synthesized, and characterized following with the anti-inflammatory, analgesic, and ulcerogenic evaluation. The investigation of the potentiality of the titled compounds (10a-j) displayed a high degree of anti-inflammatory activity. The compounds displaying potential analgesic activity were identified and validated further for evaluation of analgesic, anti-inflammatory activity, and subsequent ulcerogenic evaluation. In addition, the COX-1, COX-2, and 5-LOX analyses were carried out in vitro. Among (10a-j) series, compound 10c with para substitution of fluoro group on the benzoyl ring and two chloro groups at ortho position in phenyl ring of benzophenone was observed to have good inhibitory potency. Furthermore, the in silico docking study was performed by using AutoDock tools docking software.</description><identifier>ISSN: 0022-2860</identifier><identifier>EISSN: 1872-8014</identifier><identifier>DOI: 10.1016/j.molstruc.2022.132741</identifier><language>eng</language><publisher>Elsevier B.V</publisher><subject>5-LOX inhibition ; Analgesic ; Anti-inflammatory ; COX-1/COX-2 inhibition ; Docking study ; Heterocycle ; Ulcerogenic evaluation</subject><ispartof>Journal of molecular structure, 2022-07, Vol.1259, p.132741, Article 132741</ispartof><rights>2022 Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c312t-aa0cb86a1ace6e3d92ca098697abd210878846d31f02a15c198f16bdab4ab5933</citedby><cites>FETCH-LOGICAL-c312t-aa0cb86a1ace6e3d92ca098697abd210878846d31f02a15c198f16bdab4ab5933</cites><orcidid>0000-0002-7500-2823</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Nagesh, Khadri M.J.</creatorcontrib><creatorcontrib>Prashanth, T.</creatorcontrib><creatorcontrib>Khamees, Hussien Ahmed</creatorcontrib><creatorcontrib>Khanum, Shaukath Ara</creatorcontrib><title>Synthesis, analgesic, anti-inflammatory, COX/5-LOX inhibition, ulcerogenic evaluation, and docking study of benzimidazole bearing indole and benzophenone analogs</title><title>Journal of molecular structure</title><description>•Synthesis of benzimidazole analogs bearing benzophenone and indole moieties 10a-j.•Screening of synthesized compounds for in vivo analgesic, anti-inflammatory, and ulcerogenic evaluation.•In vitro analysis of COX-1, COX-2, and 5-LOX inhibition.•Molecular docking studies supported the investigation of the ligand binding to their target protein.•Viable dual inhibition of COX/5-LOX by the synthetic analogs. Inflammation therapy is particularly focused on the development of safer non-steroidal anti-inflammatory drugs (NSAIDs), administered to control inflammation. It is typically considered that dual-inhibition of COX/5-LOX, which improves efficacy and has fewer side effects, is an effective technique for combating inflammation. In this perspective, the series of titled compounds (10a-j) were designed, synthesized, and characterized following with the anti-inflammatory, analgesic, and ulcerogenic evaluation. The investigation of the potentiality of the titled compounds (10a-j) displayed a high degree of anti-inflammatory activity. The compounds displaying potential analgesic activity were identified and validated further for evaluation of analgesic, anti-inflammatory activity, and subsequent ulcerogenic evaluation. In addition, the COX-1, COX-2, and 5-LOX analyses were carried out in vitro. Among (10a-j) series, compound 10c with para substitution of fluoro group on the benzoyl ring and two chloro groups at ortho position in phenyl ring of benzophenone was observed to have good inhibitory potency. Furthermore, the in silico docking study was performed by using AutoDock tools docking software.</description><subject>5-LOX inhibition</subject><subject>Analgesic</subject><subject>Anti-inflammatory</subject><subject>COX-1/COX-2 inhibition</subject><subject>Docking study</subject><subject>Heterocycle</subject><subject>Ulcerogenic evaluation</subject><issn>0022-2860</issn><issn>1872-8014</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNqFUMtOwzAQtBBIlMcvIH9AU2ynTZ0bqOIlIXEAJG7Wxt60WxIb2SlS-zf8KQmFM6ed3dkZjYaxCykmUsjicj1pQ5O6uLETJZSayFzNp_KAjaSeq0wLOT1kI9EzmdKFOGYnKa2FELIXj9jX89Z3K0yUxhw8NMse2gF2lJGvG2hb6ELcjvni6e1ylj0-vXHyK6qoo-DHfNNYjGGJnizHT2g2sL-Dd9wF-05-yVO3cVseal6h31FLDnahwX6DONDk3bAOiuEhfKzQB48_ccIynbGjGpqE57_zlL3e3rws7vsodw-L68fM5lJ1GYCwlS5AgsUCc1cqC6LURTmHyikp9FzraeFyWQsFcmZlqWtZVA6qKVSzMs9PWbH3tTGkFLE2H5FaiFsjhRmKNmvzV7QZijb7onvh1V6IfbpPwmiSJfQWHUW0nXGB_rP4BuhKjrs</recordid><startdate>20220705</startdate><enddate>20220705</enddate><creator>Nagesh, Khadri M.J.</creator><creator>Prashanth, T.</creator><creator>Khamees, Hussien Ahmed</creator><creator>Khanum, Shaukath Ara</creator><general>Elsevier B.V</general><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0002-7500-2823</orcidid></search><sort><creationdate>20220705</creationdate><title>Synthesis, analgesic, anti-inflammatory, COX/5-LOX inhibition, ulcerogenic evaluation, and docking study of benzimidazole bearing indole and benzophenone analogs</title><author>Nagesh, Khadri M.J. ; Prashanth, T. ; Khamees, Hussien Ahmed ; Khanum, Shaukath Ara</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c312t-aa0cb86a1ace6e3d92ca098697abd210878846d31f02a15c198f16bdab4ab5933</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>5-LOX inhibition</topic><topic>Analgesic</topic><topic>Anti-inflammatory</topic><topic>COX-1/COX-2 inhibition</topic><topic>Docking study</topic><topic>Heterocycle</topic><topic>Ulcerogenic evaluation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nagesh, Khadri M.J.</creatorcontrib><creatorcontrib>Prashanth, T.</creatorcontrib><creatorcontrib>Khamees, Hussien Ahmed</creatorcontrib><creatorcontrib>Khanum, Shaukath Ara</creatorcontrib><collection>CrossRef</collection><jtitle>Journal of molecular structure</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nagesh, Khadri M.J.</au><au>Prashanth, T.</au><au>Khamees, Hussien Ahmed</au><au>Khanum, Shaukath Ara</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis, analgesic, anti-inflammatory, COX/5-LOX inhibition, ulcerogenic evaluation, and docking study of benzimidazole bearing indole and benzophenone analogs</atitle><jtitle>Journal of molecular structure</jtitle><date>2022-07-05</date><risdate>2022</risdate><volume>1259</volume><spage>132741</spage><pages>132741-</pages><artnum>132741</artnum><issn>0022-2860</issn><eissn>1872-8014</eissn><abstract>•Synthesis of benzimidazole analogs bearing benzophenone and indole moieties 10a-j.•Screening of synthesized compounds for in vivo analgesic, anti-inflammatory, and ulcerogenic evaluation.•In vitro analysis of COX-1, COX-2, and 5-LOX inhibition.•Molecular docking studies supported the investigation of the ligand binding to their target protein.•Viable dual inhibition of COX/5-LOX by the synthetic analogs. Inflammation therapy is particularly focused on the development of safer non-steroidal anti-inflammatory drugs (NSAIDs), administered to control inflammation. It is typically considered that dual-inhibition of COX/5-LOX, which improves efficacy and has fewer side effects, is an effective technique for combating inflammation. In this perspective, the series of titled compounds (10a-j) were designed, synthesized, and characterized following with the anti-inflammatory, analgesic, and ulcerogenic evaluation. The investigation of the potentiality of the titled compounds (10a-j) displayed a high degree of anti-inflammatory activity. The compounds displaying potential analgesic activity were identified and validated further for evaluation of analgesic, anti-inflammatory activity, and subsequent ulcerogenic evaluation. In addition, the COX-1, COX-2, and 5-LOX analyses were carried out in vitro. Among (10a-j) series, compound 10c with para substitution of fluoro group on the benzoyl ring and two chloro groups at ortho position in phenyl ring of benzophenone was observed to have good inhibitory potency. Furthermore, the in silico docking study was performed by using AutoDock tools docking software.</abstract><pub>Elsevier B.V</pub><doi>10.1016/j.molstruc.2022.132741</doi><orcidid>https://orcid.org/0000-0002-7500-2823</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0022-2860
ispartof Journal of molecular structure, 2022-07, Vol.1259, p.132741, Article 132741
issn 0022-2860
1872-8014
language eng
recordid cdi_crossref_primary_10_1016_j_molstruc_2022_132741
source ScienceDirect Freedom Collection
subjects 5-LOX inhibition
Analgesic
Anti-inflammatory
COX-1/COX-2 inhibition
Docking study
Heterocycle
Ulcerogenic evaluation
title Synthesis, analgesic, anti-inflammatory, COX/5-LOX inhibition, ulcerogenic evaluation, and docking study of benzimidazole bearing indole and benzophenone analogs
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T16%3A00%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis,%20analgesic,%20anti-inflammatory,%20COX/5-LOX%20inhibition,%20ulcerogenic%20evaluation,%20and%20docking%20study%20of%20benzimidazole%20bearing%20indole%20and%20benzophenone%20analogs&rft.jtitle=Journal%20of%20molecular%20structure&rft.au=Nagesh,%20Khadri%20M.J.&rft.date=2022-07-05&rft.volume=1259&rft.spage=132741&rft.pages=132741-&rft.artnum=132741&rft.issn=0022-2860&rft.eissn=1872-8014&rft_id=info:doi/10.1016/j.molstruc.2022.132741&rft_dat=%3Celsevier_cross%3ES0022286022004148%3C/elsevier_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c312t-aa0cb86a1ace6e3d92ca098697abd210878846d31f02a15c198f16bdab4ab5933%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true